{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:18:52Z","timestamp":1792703932710,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1053\/j.seminoncol.2013.05.009","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T23:47:21Z","timestamp":1377215241000},"page":"511-520","source":"Crossref","is-referenced-by-count":39,"title":["Non-Clear Cell Renal Cancer: Disease-Based Management and Opportunities for Targeted Therapeutic Approaches"],"prefix":"10.1053","volume":"40","author":[{"given":"W. Marston","family":"Linehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramaprasad","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2013.05.009_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00004728-199709000-00014","article-title":"Imaging features of hereditary papillary renal cancers","volume":"21","author":"Choyke","year":"1997","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib4","first-page":"1719","article-title":"Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene","volume":"58","author":"Schmidt","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-5347(05)67893-7","article-title":"Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer","volume":"163","author":"Ornstein","year":"2000","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","article-title":"Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience","volume":"165","author":"Herring","year":"2001","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nature Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2007.13.3223","article-title":"Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma","volume":"26","author":"Choueiri","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10637-010-9491-6","article-title":"Phase II trial of sunitinib in patients with metastatic non\u2013clear cell renal cell carcinoma","volume":"30","author":"Molina","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib10","first-page":"23","article-title":"First-line sunitinib in type I and papillary renal cell carcinoma (PRCC): SUPAP, a phase II study of the French Genito-Urinary Group (GETUG) and the Group of Early Phase trials (GEP)","author":"Ravaud","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2012.06.043","article-title":"A phase 2 trial of sunitinib in patients with advanced non\u2013clear cell renal cell carcinoma","volume":"62","author":"Tannir","year":"2012","journal-title":"Eur Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib12","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12032-009-9177-0","article-title":"Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies","volume":"26","author":"Dutcher","year":"2009","journal-title":"Med Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib14","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdr586","article-title":"Multicenter phase II study of sunitinib in patients with non\u2013clear cell renal cell carcinoma","volume":"23","author":"Lee","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib15","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1200\/JCO.2008.18.8821","article-title":"Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317","volume":"27","author":"Gordon","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2012.43.3383","article-title":"Phase II and biomarker study of the dual MET\/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma","volume":"31","author":"Choueiri","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/hmg\/5.9.1333","article-title":"The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses anovel gene PRCC to the TFE3 transcription factor gene","volume":"5","author":"Sidhar","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib18","doi-asserted-by":"crossref","first-page":"15294","DOI":"10.1073\/pnas.93.26.15294","article-title":"Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas","volume":"93","author":"Weterman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib19","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","article-title":"Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma","volume":"15","author":"Clark","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib20","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1038\/sj.onc.1206686","article-title":"A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)","volume":"22","author":"Argani","year":"2003","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.juro.2010.08.092","article-title":"Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors","volume":"185","author":"Malouf","year":"2011","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib22","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1073\/pnas.0931430100","article-title":"Cloning of an alpha-TFEB fusion in renal tumors harboring the t(6;11) (p21;q13) chromosome translocation","volume":"100","author":"Davis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/PAS.0b013e3181dd577e","article-title":"Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma","volume":"34","author":"Zhong","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdq029","article-title":"Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network","volume":"21","author":"Malouf","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1158\/0008-5472.CAN-06-2855","article-title":"TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition","volume":"67","author":"Tsuda","year":"2007","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib27","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1002\/cncr.27582","article-title":"Tivantinib (ARQ. 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial","volume":"118","author":"Wagner","year":"2012","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(01)67601-8","article-title":"Hereditary papillary renal cell carcinoma: clinical studies in 10 families","volume":"153","author":"Zbar","year":"1995","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaad.2006.06.026","article-title":"Multiple painful cutaneous nodules and renal mass","volume":"55","author":"Rothman","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib31","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archdermatol.2008.517","article-title":"Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer","volume":"144","author":"Stewart","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib35","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","article-title":"Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer","volume":"177","author":"Grubb","year":"2007","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib36","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cancergencyto.2009.08.018","article-title":"UOK 262 cell line, fumarate hydratase deficient (FH-\/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer","volume":"196","author":"Yang","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","article-title":"The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels","volume":"20","author":"Tong","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive carboxylation supports growth in tumour cells with defective mitochondria","volume":"481","author":"Mullen","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib41","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cncr.24230","article-title":"Hereditary kidney cancer: unique opportunity for disease-based therapy","volume":"115","author":"Linehan","year":"2009","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib42","first-page":"6510","article-title":"Efficacy of combined vegf and egfr inhibtion in metastatic papillary rencal cell carcinoma associated with hereditary leiomyomatosis and renal cell cancer","volume":"19","author":"Singer","year":"2012","journal-title":"J Canadian Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib44","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","article-title":"Succinate dehydrogenase kidney cancer: an aggressive example of the warburg effect in cancer","volume":"188","author":"Ricketts","year":"2012","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib46","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":"Germline SDHB mutations and familial renal cell carcinoma","volume":"100","author":"Ricketts","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2008.03274.x","article-title":"Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers","volume":"69","author":"Srirangalingam","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10689-009-9234-z","article-title":"SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis","volume":"8","author":"Henderson","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-0004.2009.01157.x","article-title":"Penetrance and clinical consequences of a gross SDHB deletion in a large family","volume":"75","author":"Solis","year":"2009","journal-title":"Clin Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/ERC-11-0324","article-title":"Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3","volume":"19","author":"Malinoc","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib51","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1074\/jbc.M311876200","article-title":"The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies","volume":"279","author":"Oyedotun","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02890129","article-title":"Human chromophobe renal cell carcinoma","volume":"48","author":"Thoenes","year":"1985","journal-title":"Virchows Arch B Cell Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib54","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","article-title":"Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma","volume":"27","author":"Cheville","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11523-010-0148-3","article-title":"Targeted therapies for non\u2013clear renal cell carcinoma","volume":"5","author":"Singer","year":"2010","journal-title":"Target Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib56","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons","volume":"113","author":"Birt","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib57","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.200610-1483OC","article-title":"Lung cysts, spontaneous pneumothrorax and genetic associations in 89 families with Birt-Hogg-Dub\u00e9 syndrome","volume":"175","author":"Toro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib58","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","article-title":"Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome","volume":"173","author":"Pavlovich","year":"2005","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib59","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib61","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dub\u00e9 syndrome","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports","volume":"45","author":"Toro","year":"2008","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib63","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","article-title":"Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling","volume":"103","author":"Baba","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gene.2008.02.022","article-title":"Identification and characterization of a novel folliculin-interacting protein FNIP2","volume":"415","author":"Hasumi","year":"2008","journal-title":"Gene"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib65","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Hasumi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","article-title":"Kidney-targeted Birt-Hogg-Dub\u00e9 gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys","volume":"100","author":"Baba","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib67","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib68","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.urology.2008.07.049","article-title":"Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms","volume":"72","author":"Seyam","year":"2008","journal-title":"Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib69","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/onc.2010.630","article-title":"The long and winding road to rational treatment of cancer associated with LKB1\/AMPK\/TSC\/mTORC1 signaling","volume":"30","author":"van","year":"2011","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib71","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1365-2559.1986.tb02553.x","article-title":"Collecting duct carcinoma of the kidney","volume":"10","author":"Fleming","year":"1986","journal-title":"Histopath"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0046-8177(90)90209-N","article-title":"Collecting duct carcinoma of the kidney","volume":"21","author":"Kennedy","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib73","unstructured":"Srigley JR, Moch H. Carcinoma of the collecting ducts of Bellini. In: World Health Organization classification of tumors pathology & genetics: tumors of the urinary system and male genital organs. Lyon, France: IARC; 2004:33-4."},{"key":"10.1053\/j.seminoncol.2013.05.009_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00125480-199703000-00002","article-title":"Collecting duct carcinoma of the kidney","volume":"4","author":"Amin","year":"1997","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib75","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.juro.2009.08.049","article-title":"Effect of collecting duct histology on renal cell cancer outcome","volume":"182","author":"Wright","year":"2009","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib76","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(06)00502-7","article-title":"Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan","volume":"176","author":"Tokuda","year":"2006","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib77","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.3816\/CGC.2009.n.017","article-title":"Influence of demographic factors on outcome of collecting duct carcinoma: a Surveillance, Epidemiology, and End Results (SEER) database analysis","volume":"7","author":"Pepek","year":"2009","journal-title":"Clin Genitourin Cancer"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib78","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2002.11.123","article-title":"Treatment outcome and survival associated with metastatic renal cell carcinoma of non\u2013clear-cell histology","volume":"20","author":"Motzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib79","first-page":"354","article-title":"Collecting duct carcinoma of the kidney: a report of three cases and review of the literature","volume":"29","author":"Matz","year":"1997","journal-title":"Pathology (Phila)"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib80","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10157-012-0589-3","article-title":"Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases","volume":"16","author":"Procopio","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib81","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0090-4295(01)01411-X","article-title":"Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol\/carboplatin and surgery","volume":"58","author":"Gollob","year":"2001","journal-title":"Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cncr.10204","article-title":"Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature","volume":"94","author":"Milowsky","year":"2002","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib83","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.juro.2007.01.063","article-title":"Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Genitales) study","volume":"177","author":"Oudard","year":"2007","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","article-title":"Renal medullary carcinoma. The seventh sickle cell nephropathy","volume":"19","author":"Davis","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0022-5347(01)63707-8","article-title":"Renal medullary carcinoma","volume":"159","author":"Figenshau","year":"1998","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib86","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0022-5347(05)67733-6","article-title":"Renal medullary carcinoma: can early diagnosis lead to long-term survival?","volume":"163","author":"Selby","year":"2000","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib87","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1200\/JCO.2005.05.0344","article-title":"Medullary renal cell carcinoma and response to therapy with bortezomib","volume":"24","author":"Ronnen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib88","doi-asserted-by":"crossref","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics","author":"Linehan","year":"2012","journal-title":"Genome Res"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib89","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.urology.2008.05.009","article-title":"High-dose-intensity MVAC for advanced renal medullary carcinoma: report of three cases and literature review","volume":"72","author":"Rathmell","year":"2008","journal-title":"Urol"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0065-230X(03)01005-4","article-title":"Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics","volume":"89","author":"Takahashi","year":"2003","journal-title":"Adv Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.05.009_bib91","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1464-410X.2009.09139.x","article-title":"Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy","volume":"106","author":"Schaeffer","year":"2010","journal-title":"BJU Int"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775413000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775413000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T18:58:27Z","timestamp":1563735507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775413000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0093775413000845"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2013.05.009","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}